Built for Healthcare
See how your drugs show up in AI search—for patients & clinicians
Relixir monitors how ChatGPT, Gemini, Perplexity—and clinician tools like OpenEvidence—describe your therapies, indications, dosing, and safety. Turn those insights into MLR-ready pages, FAQs, and refreshes that AI can confidently cite.
“66% of U.S. physicians used AI in practice in 2024 (up from 38% in 2023)—including clinical search via tools like OpenEvidence, documentation, and summarization...”
AI use ‘24
Year-over-year surge
Real rankings. Real results. Real growth. Relixir.
Source
“1 in 5 GPs (UK) report using AI tools such as ChatGPT for daily tasks, from documentation to diagnostic brainstorming—clinician AI search is here...”
UK GPs using AI tools
AI in care delivery
Real rankings. Real results. Real growth. Relixir.
Source
“Patients are using AI for health info: 17% of U.S. adults use chatbots at least monthly to seek medical information/advice...”
Patients using AI
AI for diagnosis/advice
Real rankings. Real results. Real growth. Relixir.
Source
Why Relixir
HCP & DTC lenses
Segment prompts, visibility, and reasoning by doctor vs patient intent.
Evidence-first drafting
Every claim traces back to labeling, guidelines, or peer-review
Compliance built-in
Reviewer roles, audit logs, red-flag term checks, and standard disclaimers.
